cellection biotin binder magnetic beads Search Results


99
Thermo Fisher synthetic biotinylated oligonucleotide
FIG. 1. Experimental design. A, specific 32P-end labeling of TFIIA. Recombinant TFIIA subunits bearing a heart muscle kinase phospho- rylation site (HMK tag) at one terminus and a His-tag at the other were overexpressed and purified from Escherichia coli by Ni-NTA chroma- tography. The tagged subunits were then joined with a partner lacking the HMK tag and labeled with [g-32P]ATP and heart muscle kinase to generate TFIIA 32P-end-labeled at the HMK tag of one subunit. B, schematic of protease footprinting protocol. To form ternary complexes, recombinant human TBP (the carboxyl-terminal 181 amino acids) and human 32P-end-labeled TFIIA were incubated with a <t>biotinylated</t> oli- gonucleotide containing the TATA box from the adenovirus E4 pro- moter immobilized on streptavidin:magnetic beads. (Binary complexes were assembled by incubating glutathione-agarose-immobilized GST- TBP with human 32P-end-labeled TFIIA, not shown.) The complexes were washed with an excess of binding buffer to remove unbound protein and then digested with limiting amounts of a broad specificity protease. The products were fractionated on high resolution SDS-poly- acrylamide gels and visualized by autoradiography. C, specific ternary complex formation. Increasing amounts of TFIIA end-labeled on the g subunit were incubated with biotinylated TATA box oligonucleotides immobilized on M-280 streptavidin resin with (lanes 3, 5, 7, and 9) or without (lanes 2, 4, 6, and 8) TBP and then washed extensively. The bound fraction was electrophoresed on standard SDS-polyacrylamide gels and autoradiographed. Lane 1 is 3% of the input end-labeled TFIIA for the experiments shown in lanes 8 and 9.
Synthetic Biotinylated Oligonucleotide, supplied by Thermo Fisher, used in various techniques. Bioz Stars score: 99/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/synthetic biotinylated oligonucleotide/product/Thermo Fisher
Average 99 stars, based on 1 article reviews
synthetic biotinylated oligonucleotide - by Bioz Stars, 2026-03
99/100 stars
  Buy from Supplier

99
Miltenyi Biotec biotinylated anti ly6g antibody
FIG. 1. Experimental design. A, specific 32P-end labeling of TFIIA. Recombinant TFIIA subunits bearing a heart muscle kinase phospho- rylation site (HMK tag) at one terminus and a His-tag at the other were overexpressed and purified from Escherichia coli by Ni-NTA chroma- tography. The tagged subunits were then joined with a partner lacking the HMK tag and labeled with [g-32P]ATP and heart muscle kinase to generate TFIIA 32P-end-labeled at the HMK tag of one subunit. B, schematic of protease footprinting protocol. To form ternary complexes, recombinant human TBP (the carboxyl-terminal 181 amino acids) and human 32P-end-labeled TFIIA were incubated with a <t>biotinylated</t> oli- gonucleotide containing the TATA box from the adenovirus E4 pro- moter immobilized on streptavidin:magnetic beads. (Binary complexes were assembled by incubating glutathione-agarose-immobilized GST- TBP with human 32P-end-labeled TFIIA, not shown.) The complexes were washed with an excess of binding buffer to remove unbound protein and then digested with limiting amounts of a broad specificity protease. The products were fractionated on high resolution SDS-poly- acrylamide gels and visualized by autoradiography. C, specific ternary complex formation. Increasing amounts of TFIIA end-labeled on the g subunit were incubated with biotinylated TATA box oligonucleotides immobilized on M-280 streptavidin resin with (lanes 3, 5, 7, and 9) or without (lanes 2, 4, 6, and 8) TBP and then washed extensively. The bound fraction was electrophoresed on standard SDS-polyacrylamide gels and autoradiographed. Lane 1 is 3% of the input end-labeled TFIIA for the experiments shown in lanes 8 and 9.
Biotinylated Anti Ly6g Antibody, supplied by Miltenyi Biotec, used in various techniques. Bioz Stars score: 99/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/biotinylated anti ly6g antibody/product/Miltenyi Biotec
Average 99 stars, based on 1 article reviews
biotinylated anti ly6g antibody - by Bioz Stars, 2026-03
99/100 stars
  Buy from Supplier

98
Thermo Fisher biotinylated dna
FIG. 1. Experimental design. A, specific 32P-end labeling of TFIIA. Recombinant TFIIA subunits bearing a heart muscle kinase phospho- rylation site (HMK tag) at one terminus and a His-tag at the other were overexpressed and purified from Escherichia coli by Ni-NTA chroma- tography. The tagged subunits were then joined with a partner lacking the HMK tag and labeled with [g-32P]ATP and heart muscle kinase to generate TFIIA 32P-end-labeled at the HMK tag of one subunit. B, schematic of protease footprinting protocol. To form ternary complexes, recombinant human TBP (the carboxyl-terminal 181 amino acids) and human 32P-end-labeled TFIIA were incubated with a <t>biotinylated</t> oli- gonucleotide containing the TATA box from the adenovirus E4 pro- moter immobilized on streptavidin:magnetic beads. (Binary complexes were assembled by incubating glutathione-agarose-immobilized GST- TBP with human 32P-end-labeled TFIIA, not shown.) The complexes were washed with an excess of binding buffer to remove unbound protein and then digested with limiting amounts of a broad specificity protease. The products were fractionated on high resolution SDS-poly- acrylamide gels and visualized by autoradiography. C, specific ternary complex formation. Increasing amounts of TFIIA end-labeled on the g subunit were incubated with biotinylated TATA box oligonucleotides immobilized on M-280 streptavidin resin with (lanes 3, 5, 7, and 9) or without (lanes 2, 4, 6, and 8) TBP and then washed extensively. The bound fraction was electrophoresed on standard SDS-polyacrylamide gels and autoradiographed. Lane 1 is 3% of the input end-labeled TFIIA for the experiments shown in lanes 8 and 9.
Biotinylated Dna, supplied by Thermo Fisher, used in various techniques. Bioz Stars score: 98/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/biotinylated dna/product/Thermo Fisher
Average 98 stars, based on 1 article reviews
biotinylated dna - by Bioz Stars, 2026-03
98/100 stars
  Buy from Supplier

94
Miltenyi Biotec biotinylated anti cd115 antibodies
FIG. 1. Experimental design. A, specific 32P-end labeling of TFIIA. Recombinant TFIIA subunits bearing a heart muscle kinase phospho- rylation site (HMK tag) at one terminus and a His-tag at the other were overexpressed and purified from Escherichia coli by Ni-NTA chroma- tography. The tagged subunits were then joined with a partner lacking the HMK tag and labeled with [g-32P]ATP and heart muscle kinase to generate TFIIA 32P-end-labeled at the HMK tag of one subunit. B, schematic of protease footprinting protocol. To form ternary complexes, recombinant human TBP (the carboxyl-terminal 181 amino acids) and human 32P-end-labeled TFIIA were incubated with a <t>biotinylated</t> oli- gonucleotide containing the TATA box from the adenovirus E4 pro- moter immobilized on streptavidin:magnetic beads. (Binary complexes were assembled by incubating glutathione-agarose-immobilized GST- TBP with human 32P-end-labeled TFIIA, not shown.) The complexes were washed with an excess of binding buffer to remove unbound protein and then digested with limiting amounts of a broad specificity protease. The products were fractionated on high resolution SDS-poly- acrylamide gels and visualized by autoradiography. C, specific ternary complex formation. Increasing amounts of TFIIA end-labeled on the g subunit were incubated with biotinylated TATA box oligonucleotides immobilized on M-280 streptavidin resin with (lanes 3, 5, 7, and 9) or without (lanes 2, 4, 6, and 8) TBP and then washed extensively. The bound fraction was electrophoresed on standard SDS-polyacrylamide gels and autoradiographed. Lane 1 is 3% of the input end-labeled TFIIA for the experiments shown in lanes 8 and 9.
Biotinylated Anti Cd115 Antibodies, supplied by Miltenyi Biotec, used in various techniques. Bioz Stars score: 94/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/biotinylated anti cd115 antibodies/product/Miltenyi Biotec
Average 94 stars, based on 1 article reviews
biotinylated anti cd115 antibodies - by Bioz Stars, 2026-03
94/100 stars
  Buy from Supplier

95
Miltenyi Biotec anti ly6g biotin
FIG. 1. Experimental design. A, specific 32P-end labeling of TFIIA. Recombinant TFIIA subunits bearing a heart muscle kinase phospho- rylation site (HMK tag) at one terminus and a His-tag at the other were overexpressed and purified from Escherichia coli by Ni-NTA chroma- tography. The tagged subunits were then joined with a partner lacking the HMK tag and labeled with [g-32P]ATP and heart muscle kinase to generate TFIIA 32P-end-labeled at the HMK tag of one subunit. B, schematic of protease footprinting protocol. To form ternary complexes, recombinant human TBP (the carboxyl-terminal 181 amino acids) and human 32P-end-labeled TFIIA were incubated with a <t>biotinylated</t> oli- gonucleotide containing the TATA box from the adenovirus E4 pro- moter immobilized on streptavidin:magnetic beads. (Binary complexes were assembled by incubating glutathione-agarose-immobilized GST- TBP with human 32P-end-labeled TFIIA, not shown.) The complexes were washed with an excess of binding buffer to remove unbound protein and then digested with limiting amounts of a broad specificity protease. The products were fractionated on high resolution SDS-poly- acrylamide gels and visualized by autoradiography. C, specific ternary complex formation. Increasing amounts of TFIIA end-labeled on the g subunit were incubated with biotinylated TATA box oligonucleotides immobilized on M-280 streptavidin resin with (lanes 3, 5, 7, and 9) or without (lanes 2, 4, 6, and 8) TBP and then washed extensively. The bound fraction was electrophoresed on standard SDS-polyacrylamide gels and autoradiographed. Lane 1 is 3% of the input end-labeled TFIIA for the experiments shown in lanes 8 and 9.
Anti Ly6g Biotin, supplied by Miltenyi Biotec, used in various techniques. Bioz Stars score: 95/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/anti ly6g biotin/product/Miltenyi Biotec
Average 95 stars, based on 1 article reviews
anti ly6g biotin - by Bioz Stars, 2026-03
95/100 stars
  Buy from Supplier

90
Miltenyi Biotec cd154-biotin
FIG. 1. Experimental design. A, specific 32P-end labeling of TFIIA. Recombinant TFIIA subunits bearing a heart muscle kinase phospho- rylation site (HMK tag) at one terminus and a His-tag at the other were overexpressed and purified from Escherichia coli by Ni-NTA chroma- tography. The tagged subunits were then joined with a partner lacking the HMK tag and labeled with [g-32P]ATP and heart muscle kinase to generate TFIIA 32P-end-labeled at the HMK tag of one subunit. B, schematic of protease footprinting protocol. To form ternary complexes, recombinant human TBP (the carboxyl-terminal 181 amino acids) and human 32P-end-labeled TFIIA were incubated with a <t>biotinylated</t> oli- gonucleotide containing the TATA box from the adenovirus E4 pro- moter immobilized on streptavidin:magnetic beads. (Binary complexes were assembled by incubating glutathione-agarose-immobilized GST- TBP with human 32P-end-labeled TFIIA, not shown.) The complexes were washed with an excess of binding buffer to remove unbound protein and then digested with limiting amounts of a broad specificity protease. The products were fractionated on high resolution SDS-poly- acrylamide gels and visualized by autoradiography. C, specific ternary complex formation. Increasing amounts of TFIIA end-labeled on the g subunit were incubated with biotinylated TATA box oligonucleotides immobilized on M-280 streptavidin resin with (lanes 3, 5, 7, and 9) or without (lanes 2, 4, 6, and 8) TBP and then washed extensively. The bound fraction was electrophoresed on standard SDS-polyacrylamide gels and autoradiographed. Lane 1 is 3% of the input end-labeled TFIIA for the experiments shown in lanes 8 and 9.
Cd154 Biotin, supplied by Miltenyi Biotec, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/cd154-biotin/product/Miltenyi Biotec
Average 90 stars, based on 1 article reviews
cd154-biotin - by Bioz Stars, 2026-03
90/100 stars
  Buy from Supplier

99
Miltenyi Biotec anti biotin magnetic separation kit
FIG. 1. Experimental design. A, specific 32P-end labeling of TFIIA. Recombinant TFIIA subunits bearing a heart muscle kinase phospho- rylation site (HMK tag) at one terminus and a His-tag at the other were overexpressed and purified from Escherichia coli by Ni-NTA chroma- tography. The tagged subunits were then joined with a partner lacking the HMK tag and labeled with [g-32P]ATP and heart muscle kinase to generate TFIIA 32P-end-labeled at the HMK tag of one subunit. B, schematic of protease footprinting protocol. To form ternary complexes, recombinant human TBP (the carboxyl-terminal 181 amino acids) and human 32P-end-labeled TFIIA were incubated with a <t>biotinylated</t> oli- gonucleotide containing the TATA box from the adenovirus E4 pro- moter immobilized on streptavidin:magnetic beads. (Binary complexes were assembled by incubating glutathione-agarose-immobilized GST- TBP with human 32P-end-labeled TFIIA, not shown.) The complexes were washed with an excess of binding buffer to remove unbound protein and then digested with limiting amounts of a broad specificity protease. The products were fractionated on high resolution SDS-poly- acrylamide gels and visualized by autoradiography. C, specific ternary complex formation. Increasing amounts of TFIIA end-labeled on the g subunit were incubated with biotinylated TATA box oligonucleotides immobilized on M-280 streptavidin resin with (lanes 3, 5, 7, and 9) or without (lanes 2, 4, 6, and 8) TBP and then washed extensively. The bound fraction was electrophoresed on standard SDS-polyacrylamide gels and autoradiographed. Lane 1 is 3% of the input end-labeled TFIIA for the experiments shown in lanes 8 and 9.
Anti Biotin Magnetic Separation Kit, supplied by Miltenyi Biotec, used in various techniques. Bioz Stars score: 99/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/anti biotin magnetic separation kit/product/Miltenyi Biotec
Average 99 stars, based on 1 article reviews
anti biotin magnetic separation kit - by Bioz Stars, 2026-03
99/100 stars
  Buy from Supplier

95
Miltenyi Biotec human cd2
FIG. 1. Experimental design. A, specific 32P-end labeling of TFIIA. Recombinant TFIIA subunits bearing a heart muscle kinase phospho- rylation site (HMK tag) at one terminus and a His-tag at the other were overexpressed and purified from Escherichia coli by Ni-NTA chroma- tography. The tagged subunits were then joined with a partner lacking the HMK tag and labeled with [g-32P]ATP and heart muscle kinase to generate TFIIA 32P-end-labeled at the HMK tag of one subunit. B, schematic of protease footprinting protocol. To form ternary complexes, recombinant human TBP (the carboxyl-terminal 181 amino acids) and human 32P-end-labeled TFIIA were incubated with a <t>biotinylated</t> oli- gonucleotide containing the TATA box from the adenovirus E4 pro- moter immobilized on streptavidin:magnetic beads. (Binary complexes were assembled by incubating glutathione-agarose-immobilized GST- TBP with human 32P-end-labeled TFIIA, not shown.) The complexes were washed with an excess of binding buffer to remove unbound protein and then digested with limiting amounts of a broad specificity protease. The products were fractionated on high resolution SDS-poly- acrylamide gels and visualized by autoradiography. C, specific ternary complex formation. Increasing amounts of TFIIA end-labeled on the g subunit were incubated with biotinylated TATA box oligonucleotides immobilized on M-280 streptavidin resin with (lanes 3, 5, 7, and 9) or without (lanes 2, 4, 6, and 8) TBP and then washed extensively. The bound fraction was electrophoresed on standard SDS-polyacrylamide gels and autoradiographed. Lane 1 is 3% of the input end-labeled TFIIA for the experiments shown in lanes 8 and 9.
Human Cd2, supplied by Miltenyi Biotec, used in various techniques. Bioz Stars score: 95/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/human cd2/product/Miltenyi Biotec
Average 95 stars, based on 1 article reviews
human cd2 - by Bioz Stars, 2026-03
95/100 stars
  Buy from Supplier

96
Miltenyi Biotec anti cd3 biotin
FIG. 1. Experimental design. A, specific 32P-end labeling of TFIIA. Recombinant TFIIA subunits bearing a heart muscle kinase phospho- rylation site (HMK tag) at one terminus and a His-tag at the other were overexpressed and purified from Escherichia coli by Ni-NTA chroma- tography. The tagged subunits were then joined with a partner lacking the HMK tag and labeled with [g-32P]ATP and heart muscle kinase to generate TFIIA 32P-end-labeled at the HMK tag of one subunit. B, schematic of protease footprinting protocol. To form ternary complexes, recombinant human TBP (the carboxyl-terminal 181 amino acids) and human 32P-end-labeled TFIIA were incubated with a <t>biotinylated</t> oli- gonucleotide containing the TATA box from the adenovirus E4 pro- moter immobilized on streptavidin:magnetic beads. (Binary complexes were assembled by incubating glutathione-agarose-immobilized GST- TBP with human 32P-end-labeled TFIIA, not shown.) The complexes were washed with an excess of binding buffer to remove unbound protein and then digested with limiting amounts of a broad specificity protease. The products were fractionated on high resolution SDS-poly- acrylamide gels and visualized by autoradiography. C, specific ternary complex formation. Increasing amounts of TFIIA end-labeled on the g subunit were incubated with biotinylated TATA box oligonucleotides immobilized on M-280 streptavidin resin with (lanes 3, 5, 7, and 9) or without (lanes 2, 4, 6, and 8) TBP and then washed extensively. The bound fraction was electrophoresed on standard SDS-polyacrylamide gels and autoradiographed. Lane 1 is 3% of the input end-labeled TFIIA for the experiments shown in lanes 8 and 9.
Anti Cd3 Biotin, supplied by Miltenyi Biotec, used in various techniques. Bioz Stars score: 96/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/anti cd3 biotin/product/Miltenyi Biotec
Average 96 stars, based on 1 article reviews
anti cd3 biotin - by Bioz Stars, 2026-03
96/100 stars
  Buy from Supplier

99
Miltenyi Biotec biotinylated abs cd3
FIG. 1. Experimental design. A, specific 32P-end labeling of TFIIA. Recombinant TFIIA subunits bearing a heart muscle kinase phospho- rylation site (HMK tag) at one terminus and a His-tag at the other were overexpressed and purified from Escherichia coli by Ni-NTA chroma- tography. The tagged subunits were then joined with a partner lacking the HMK tag and labeled with [g-32P]ATP and heart muscle kinase to generate TFIIA 32P-end-labeled at the HMK tag of one subunit. B, schematic of protease footprinting protocol. To form ternary complexes, recombinant human TBP (the carboxyl-terminal 181 amino acids) and human 32P-end-labeled TFIIA were incubated with a <t>biotinylated</t> oli- gonucleotide containing the TATA box from the adenovirus E4 pro- moter immobilized on streptavidin:magnetic beads. (Binary complexes were assembled by incubating glutathione-agarose-immobilized GST- TBP with human 32P-end-labeled TFIIA, not shown.) The complexes were washed with an excess of binding buffer to remove unbound protein and then digested with limiting amounts of a broad specificity protease. The products were fractionated on high resolution SDS-poly- acrylamide gels and visualized by autoradiography. C, specific ternary complex formation. Increasing amounts of TFIIA end-labeled on the g subunit were incubated with biotinylated TATA box oligonucleotides immobilized on M-280 streptavidin resin with (lanes 3, 5, 7, and 9) or without (lanes 2, 4, 6, and 8) TBP and then washed extensively. The bound fraction was electrophoresed on standard SDS-polyacrylamide gels and autoradiographed. Lane 1 is 3% of the input end-labeled TFIIA for the experiments shown in lanes 8 and 9.
Biotinylated Abs Cd3, supplied by Miltenyi Biotec, used in various techniques. Bioz Stars score: 99/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/biotinylated abs cd3/product/Miltenyi Biotec
Average 99 stars, based on 1 article reviews
biotinylated abs cd3 - by Bioz Stars, 2026-03
99/100 stars
  Buy from Supplier

95
Jackson Immuno ab 11144129 brdu biotin
FIG. 1. Experimental design. A, specific 32P-end labeling of TFIIA. Recombinant TFIIA subunits bearing a heart muscle kinase phospho- rylation site (HMK tag) at one terminus and a His-tag at the other were overexpressed and purified from Escherichia coli by Ni-NTA chroma- tography. The tagged subunits were then joined with a partner lacking the HMK tag and labeled with [g-32P]ATP and heart muscle kinase to generate TFIIA 32P-end-labeled at the HMK tag of one subunit. B, schematic of protease footprinting protocol. To form ternary complexes, recombinant human TBP (the carboxyl-terminal 181 amino acids) and human 32P-end-labeled TFIIA were incubated with a <t>biotinylated</t> oli- gonucleotide containing the TATA box from the adenovirus E4 pro- moter immobilized on streptavidin:magnetic beads. (Binary complexes were assembled by incubating glutathione-agarose-immobilized GST- TBP with human 32P-end-labeled TFIIA, not shown.) The complexes were washed with an excess of binding buffer to remove unbound protein and then digested with limiting amounts of a broad specificity protease. The products were fractionated on high resolution SDS-poly- acrylamide gels and visualized by autoradiography. C, specific ternary complex formation. Increasing amounts of TFIIA end-labeled on the g subunit were incubated with biotinylated TATA box oligonucleotides immobilized on M-280 streptavidin resin with (lanes 3, 5, 7, and 9) or without (lanes 2, 4, 6, and 8) TBP and then washed extensively. The bound fraction was electrophoresed on standard SDS-polyacrylamide gels and autoradiographed. Lane 1 is 3% of the input end-labeled TFIIA for the experiments shown in lanes 8 and 9.
Ab 11144129 Brdu Biotin, supplied by Jackson Immuno, used in various techniques. Bioz Stars score: 95/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/ab 11144129 brdu biotin/product/Jackson Immuno
Average 95 stars, based on 1 article reviews
ab 11144129 brdu biotin - by Bioz Stars, 2026-03
95/100 stars
  Buy from Supplier

96
Biotium mtsea biotin xx
KEY RESOURCES TABLE
Mtsea Biotin Xx, supplied by Biotium, used in various techniques. Bioz Stars score: 96/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/mtsea biotin xx/product/Biotium
Average 96 stars, based on 1 article reviews
mtsea biotin xx - by Bioz Stars, 2026-03
96/100 stars
  Buy from Supplier

Image Search Results


FIG. 1. Experimental design. A, specific 32P-end labeling of TFIIA. Recombinant TFIIA subunits bearing a heart muscle kinase phospho- rylation site (HMK tag) at one terminus and a His-tag at the other were overexpressed and purified from Escherichia coli by Ni-NTA chroma- tography. The tagged subunits were then joined with a partner lacking the HMK tag and labeled with [g-32P]ATP and heart muscle kinase to generate TFIIA 32P-end-labeled at the HMK tag of one subunit. B, schematic of protease footprinting protocol. To form ternary complexes, recombinant human TBP (the carboxyl-terminal 181 amino acids) and human 32P-end-labeled TFIIA were incubated with a biotinylated oli- gonucleotide containing the TATA box from the adenovirus E4 pro- moter immobilized on streptavidin:magnetic beads. (Binary complexes were assembled by incubating glutathione-agarose-immobilized GST- TBP with human 32P-end-labeled TFIIA, not shown.) The complexes were washed with an excess of binding buffer to remove unbound protein and then digested with limiting amounts of a broad specificity protease. The products were fractionated on high resolution SDS-poly- acrylamide gels and visualized by autoradiography. C, specific ternary complex formation. Increasing amounts of TFIIA end-labeled on the g subunit were incubated with biotinylated TATA box oligonucleotides immobilized on M-280 streptavidin resin with (lanes 3, 5, 7, and 9) or without (lanes 2, 4, 6, and 8) TBP and then washed extensively. The bound fraction was electrophoresed on standard SDS-polyacrylamide gels and autoradiographed. Lane 1 is 3% of the input end-labeled TFIIA for the experiments shown in lanes 8 and 9.

Journal: The Journal of biological chemistry

Article Title: Protease footprinting analysis of ternary complex formation by human TFIIA.

doi: 10.1074/jbc.272.2.1180

Figure Lengend Snippet: FIG. 1. Experimental design. A, specific 32P-end labeling of TFIIA. Recombinant TFIIA subunits bearing a heart muscle kinase phospho- rylation site (HMK tag) at one terminus and a His-tag at the other were overexpressed and purified from Escherichia coli by Ni-NTA chroma- tography. The tagged subunits were then joined with a partner lacking the HMK tag and labeled with [g-32P]ATP and heart muscle kinase to generate TFIIA 32P-end-labeled at the HMK tag of one subunit. B, schematic of protease footprinting protocol. To form ternary complexes, recombinant human TBP (the carboxyl-terminal 181 amino acids) and human 32P-end-labeled TFIIA were incubated with a biotinylated oli- gonucleotide containing the TATA box from the adenovirus E4 pro- moter immobilized on streptavidin:magnetic beads. (Binary complexes were assembled by incubating glutathione-agarose-immobilized GST- TBP with human 32P-end-labeled TFIIA, not shown.) The complexes were washed with an excess of binding buffer to remove unbound protein and then digested with limiting amounts of a broad specificity protease. The products were fractionated on high resolution SDS-poly- acrylamide gels and visualized by autoradiography. C, specific ternary complex formation. Increasing amounts of TFIIA end-labeled on the g subunit were incubated with biotinylated TATA box oligonucleotides immobilized on M-280 streptavidin resin with (lanes 3, 5, 7, and 9) or without (lanes 2, 4, 6, and 8) TBP and then washed extensively. The bound fraction was electrophoresed on standard SDS-polyacrylamide gels and autoradiographed. Lane 1 is 3% of the input end-labeled TFIIA for the experiments shown in lanes 8 and 9.

Article Snippet: Complex Formation and Proteolysis—TBP-TFIIA-TATA box ternary complexes were formed in a 50-ml mixture containing 3 pmol of biotinylated adenovirus E4 DNA template, a synthetic biotinylated oligonucleotide (biotin-59-GGATCCCCAGTCCTATATATACTCGCTCTGC-39) immobilized on streptavidin-conjugated M-280 magnetic beads (Dynal), with 500 ng of TBP, and 400 ng of 32P-labeled TFIIA.

Techniques: End Labeling, Recombinant, Purification, Labeling, Footprinting, Incubation, Magnetic Beads, Binding Assay, Autoradiography

KEY RESOURCES TABLE

Journal: Cell reports

Article Title: Functional elements of the cis -regulatory lincRNA-p21

doi: 10.1016/j.celrep.2022.110687

Figure Lengend Snippet: KEY RESOURCES TABLE

Article Snippet: 50 μg of total RNA was biotinylated using MTSEA biotin-XX (Biotium) and enriched using streptavidin as previously described ( Schofield et al., 2018 ).

Techniques: Recombinant, Western Blot, Hybridization, Plasmid Preparation, Protease Inhibitor, Magnetic Beads, PCR Cloning, Software